China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SHE:000999) — Stock Price
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SHE:000999) is currently trading at CN¥25.27 CNY, up 0.56% today. Over the past 52 weeks, shares have ranged between CN¥22.16 and CN¥31.67. This page tracks China Resources Sanjiu Medical & Pharmaceutical Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of China Resources Sanjiu Medical & Pharmac.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) Stock Price Chart — Daily History & Trading Volume
The chart below tracks China Resources Sanjiu Medical & Pharmaceutical Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Income Statement — Revenue, Profit & Earnings by Year
China Resources Sanjiu Medical & Pharmaceutical Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥27.62 Billion | CN¥24.74 Billion | CN¥18.08 Billion | CN¥15.54 Billion | CN¥13.64 Billion |
| Cost of Revenue | CN¥13.43 Billion | CN¥11.67 Billion | CN¥8.35 Billion | CN¥6.56 Billion | CN¥5.14 Billion |
| Gross Profit | CN¥14.18 Billion | CN¥13.06 Billion | CN¥9.73 Billion | CN¥8.98 Billion | CN¥8.49 Billion |
| Research & Development | CN¥801.75 Million | CN¥767.60 Million | CN¥612.28 Million | CN¥30.62 Million | CN¥459.84 Million |
| SG&A | CN¥382.42 Million | CN¥362.74 Million | CN¥1.06 Billion | CN¥257.32 Million | CN¥236.95 Million |
| Total Operating Expenses | CN¥9.71 Billion | CN¥9.31 Billion | CN¥6.78 Billion | CN¥6.51 Billion | CN¥6.42 Billion |
| Operating Income | CN¥4.48 Billion | CN¥3.75 Billion | CN¥2.95 Billion | CN¥2.47 Billion | CN¥2.07 Billion |
| EBITDA | CN¥4.83 Billion | CN¥4.23 Billion | CN¥3.25 Billion | CN¥2.64 Billion | CN¥2.28 Billion |
| EBIT | CN¥4.19 Billion | CN¥3.54 Billion | CN¥2.78 Billion | CN¥2.21 Billion | CN¥1.89 Billion |
| Interest Expense | CN¥84.07 Million | CN¥85.17 Million | CN¥22.74 Million | CN¥16.53 Million | CN¥6.89 Million |
| Income Before Tax | CN¥4.59 Billion | CN¥3.75 Billion | CN¥2.96 Billion | CN¥2.44 Billion | CN¥2.06 Billion |
| Income Tax Expense | CN¥815.87 Million | CN¥580.97 Million | CN¥466.43 Million | CN¥345.41 Million | CN¥441.89 Million |
| Net Income | CN¥3.37 Billion | CN¥2.85 Billion | CN¥2.45 Billion | CN¥2.06 Billion | CN¥1.60 Billion |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes China Resources Sanjiu Medical & Pharmaceutical Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥40.08 Billion | CN¥40.15 Billion | CN¥27.12 Billion | CN¥24.31 Billion | CN¥22.01 Billion |
| Total Current Assets | CN¥21.88 Billion | CN¥22.52 Billion | CN¥11.99 Billion | CN¥12.48 Billion | CN¥10.93 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥1.68 Billion | CN¥1.46 Billion | — | CN¥1.22 Billion | CN¥200.18 Million |
| Net Receivables | CN¥9.20 Billion | CN¥8.58 Billion | CN¥5.64 Billion | CN¥3.98 Billion | CN¥4.81 Billion |
| Inventory | CN¥4.93 Billion | CN¥5.11 Billion | CN¥2.50 Billion | CN¥2.31 Billion | CN¥1.76 Billion |
| Property, Plant & Equipment | — | — | — | CN¥4.23 Billion | CN¥3.77 Billion |
| Goodwill | CN¥5.12 Billion | CN¥5.12 Billion | CN¥3.99 Billion | CN¥4.06 Billion | CN¥4.10 Billion |
| Total Liabilities | CN¥14.83 Billion | CN¥15.89 Billion | CN¥9.59 Billion | CN¥8.60 Billion | CN¥7.95 Billion |
| Total Current Liabilities | CN¥13.61 Billion | CN¥12.95 Billion | CN¥8.67 Billion | CN¥7.78 Billion | CN¥7.30 Billion |
| Long-term Debt | CN¥177.94 Million | CN¥1.80 Billion | CN¥50.22 Million | CN¥7.97 Million | — |
| Net Debt | CN¥-3.89 Billion | CN¥-3.96 Billion | CN¥-2.76 Billion | CN¥-2.86 Billion | CN¥-3.79 Billion |
| Total Stockholder Equity | CN¥19.90 Billion | CN¥18.97 Billion | CN¥17.01 Billion | CN¥15.28 Billion | CN¥13.73 Billion |
| Retained Earnings | CN¥16.12 Billion | CN¥15.63 Billion | CN¥13.76 Billion | CN¥12.13 Billion | CN¥10.58 Billion |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how China Resources Sanjiu Medical & Pharmaceutical Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥4.40 Billion | CN¥4.22 Billion | CN¥3.01 Billion | CN¥1.87 Billion | CN¥2.22 Billion |
| Capital Expenditures | CN¥790.07 Million | CN¥857.21 Million | CN¥951.57 Million | CN¥870.80 Million | CN¥621.82 Million |
| Free Cash Flow | CN¥3.61 Billion | CN¥3.33 Billion | CN¥2.05 Billion | CN¥999.72 Million | CN¥1.60 Billion |
| Investing Cash Flow | CN¥-1.13 Billion | CN¥-821.74 Million | CN¥-2.48 Billion | CN¥-1.79 Billion | CN¥-659.34 Million |
| Financing Cash Flow | CN¥-4.63 Billion | CN¥450.42 Million | CN¥-575.45 Million | CN¥-653.11 Million | CN¥-1.47 Billion |
| Dividends Paid | CN¥2.83 Billion | CN¥1.06 Billion | CN¥841.85 Million | CN¥496.14 Million | CN¥420.93 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥838.20 Million | CN¥796.67 Million | CN¥522.74 Million | CN¥476.20 Million | CN¥391.51 Million |
| Change in Cash | CN¥-1.35 Billion | CN¥3.85 Billion | CN¥-41.93 Million | CN¥-575.41 Million | CN¥90.92 Million |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track China Resources Sanjiu Medical & Pharmaceutical Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 24, 2025 | 0.33 | 0.40 | -17.50% |
| Aug 15, 2025 | 0.10 | 0.68 | -85.29% |
| Apr 28, 2025 | 0.76 | 0.63 | +20.63% |
| Mar 13, 2025 | 0.31 | 0.32 | -3.13% |
| Oct 25, 2024 | 0.35 | 0.46 | -23.91% |
| Aug 23, 2024 | 0.62 | 0.60 | +3.33% |
| Apr 19, 2024 | 0.82 | 0.62 | +32.26% |
| Mar 22, 2024 | 0.46 | 0.46 | +0.00% |